Coiled Therapeutics, a clinical-stage oncology company developing precision medicines for hard-to-treat cancers, has commenced trading on the AIM market under ticker COIL. The announcement is primarily a listing update with limited operational or financial detail, making the immediate market impact modest.
Coiled Therapeutics, a clinical-stage oncology company developing precision medicines for hard-to-treat cancers, has commenced trading on the AIM market under ticker COIL. The announcement is primarily a listing update with limited operational or financial detail, making the immediate market impact modest.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.10
